WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO), reported today that it has engaged CorProminence, LLC for investor relations services. CorProminence is a New York -based investor relations and strategic advisory firm with a business focus on small to mid-size companies.

WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ: NURO) reported today the Quell ® app is now available in Google Play. Quell is an over-the-counter wearable pain relief device that utilizes proprietary non-invasive neurostimulation technology to provide relief from chronic pain.

WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO), reported that Quell was featured on ABC's Good Morning America on September 17 in a segment titled " Erase Your Pain ". Good Morning America is the #1 morning show in the US, reaching nearly 5 million households each week.

WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) reported purchases during August 2015 of the company's common stock by its Chief Executive Officer, Dr. Shai N. Gozani and Chief Financial Officer, Thomas T. Higgins . Details of these transactions may be found on the U.S.

BOSTON --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today announced that its Quell Wearable Pain Relief Technology will be exhibited at the Pri-Med East Annual Conference in Boston on September 18-20, 2015 . The Pri-Med East Annual Conference curriculum is developed with the American College

WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. ( NURO ), announced today that the Quell Wearable Pain Relief Device is now available on Amazon. "Most of our consumers are already on Amazon and appreciate the platform's convenience and first class customer service.

BOSTON --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO) today announced that its Quell Wearable Pain Relief Technology will be featured at the PAINWeek 2015 National Conference this week in Las Vegas, Nevada . PAINWeek is the nation's largest pain conference for frontline clinicians with an

WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. ( NURO ), a health-care company that develops wearable medical technology and point-of-care tests, reported that Shai N. Gozani M.D ., Ph.D., President and Chief Executive Officer, is scheduled to speak at the Rodman & Renshaw 17 th Annual Global

WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. ( NURO ), an innovative health-care company that develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases and sleep disorders, announced today that the Quell

WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. ( NURO ), an innovative health-care company that develops wearable medical technology and point-of-care tests that help patients and physicians better manage chronic pain, nerve diseases, and sleep disorders, today announced preliminary results